Functional Imaging Unit, Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet Glostrup, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Neurophysiology, The Neuroscience Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Geroscience. 2024 Feb;46(1):769-782. doi: 10.1007/s11357-023-01031-w. Epub 2023 Dec 16.
Alzheimer's disease (AD) is characterized by the accumulation of amyloid beta (Aβ) in the brain. The deposition of Aβ is believed to initiate a detrimental cascade, including cerebral hypometabolism, accelerated brain atrophy, and cognitive problems-ultimately resulting in AD. However, the timing and causality of the cascade resulting in AD are not yet fully established. Therefore, we examined whether early Aβ accumulation affects cerebral glucose metabolism, atrophy rate, and age-related cognitive decline before the onset of neurodegenerative disease.
Participants from the Metropolit 1953 Danish Male Birth Cohort underwent brain positron emission tomography (PET) imaging using the radiotracers [C]Pittsburgh Compound-B (PiB) (N = 70) and [F]Fluorodeoxyglucose (FDG) (N = 76) to assess cerebral Aβ accumulation and glucose metabolism, respectively. The atrophy rate was calculated from anatomical magnetic resonance imaging (MRI) scans conducted presently and 10 years ago. Cognitive decline was examined from neurophysiological tests conducted presently and ten or 5 years ago.
Higher Aβ accumulation in AD-critical brain regions correlated with greater visual memory decline (p = 0.023). Aβ accumulation did not correlate with brain atrophy rates. Increased cerebral glucose metabolism in AD-susceptible regions correlated with worse verbal memory performance (p = 0.040).
Aβ accumulation in known AD-related areas was associated with subtle cognitive deficits. The association was observed before hypometabolism or accelerated brain atrophy, suggesting that Aβ accumulation is involved early in age-related cognitive dysfunction. The association between hypermetabolism and worse memory performance may be due to early compensatory mechanisms adapting for malfunctioning neurons by increasing metabolism.
阿尔茨海默病(AD)的特征是大脑中β淀粉样蛋白(Aβ)的积累。据信,Aβ的沉积会引发有害的级联反应,包括脑代谢低下、加速脑萎缩和认知问题——最终导致 AD。然而,导致 AD 的级联反应的时间和因果关系尚未完全确定。因此,我们研究了在神经退行性疾病发作之前,早期 Aβ积累是否会影响大脑葡萄糖代谢、萎缩率和与年龄相关的认知衰退。
来自大都会 1953 年丹麦男性出生队列的参与者接受了脑正电子发射断层扫描(PET)成像,使用放射性示踪剂 [C]匹兹堡化合物-B(PiB)(N=70)和 [F]氟脱氧葡萄糖(FDG)(N=76)分别评估大脑中的 Aβ积累和葡萄糖代谢。萎缩率是根据目前和 10 年前进行的解剖磁共振成像(MRI)扫描计算得出的。认知衰退是通过目前和 10 年前或 5 年前进行的神经生理测试来检查的。
AD 关键大脑区域的 Aβ积累与视觉记忆下降幅度更大相关(p=0.023)。Aβ 积累与脑萎缩率无关。AD 易感区域的大脑葡萄糖代谢增加与言语记忆表现更差相关(p=0.040)。
已知与 AD 相关的区域的 Aβ 积累与细微的认知缺陷有关。在低代谢或加速脑萎缩之前就观察到了这种关联,这表明 Aβ 积累很早就参与了与年龄相关的认知功能障碍。代谢亢进与记忆表现更差之间的关联可能是由于早期代偿机制通过增加代谢来适应功能障碍的神经元。